FDA Clearance Tracker · P210027
QDOT MICRO System
Last checked: Nov 20, 2026Latest source record: Nov 23, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Nov 23, 2022
Approved
Time to decision
505 days
Received Jul 6, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P210027
- Device name
- QDOT MICRO System
- Applicant
- Biosense Webster, Inc.
- Applicant location
- Irvine, CA
- Received
- Jul 6, 2021
- Decided
- Nov 23, 2022
- Decision
- Approved
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for the Biosense Webster QDOT MICRO Catheter and related accessory devices. The device is indicated for catheter-based cardiac electrophysiological mapping (stimulating and recording) and, when used with a compatible RF generator, for the treatment of:1) Type I atrial flutter in patients age 18 or older; and2) Drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with compatible three-dimensional electroanatomic mapping systems. The QDOT MICRO Catheter provides a real-time measurement of contact force between the catheter tip and heart wall, as well as location information when used with CARTO® 3 Navigation System.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OAE. The earliest in FDA's data is P030031-S011, decided Feb 6, 2009.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Biosense Webster, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Dual Energy THERMOCOOL SMARTTOUCH SF SystemPMA supplement
P030031-S141 · Decided Jul 1, 2026 · 279 days after receipt · Panel Track
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
K252972 · Decided Feb 20, 2026 · 156 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
K254085 · Decided Jan 18, 2026 · 31 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.